Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Crinetics Pharmaceuticals Inc (CRNX)
Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,203,504
  • Shares Outstanding, K 69,596
  • Annual Sales, $ 4,740 K
  • Annual Income, $ -163,920 K
  • 60-Month Beta 0.62
  • Price/Sales 710.01
  • Price/Cash Flow N/A
  • Price/Book 5.07
Trade CRNX with:

Options Overview Details

View History
  • Implied Volatility 60.60% ( +4.38%)
  • Historical Volatility 56.45%
  • IV Percentile 27%
  • IV Rank 4.22%
  • IV High 258.85% on 09/06/23
  • IV Low 51.86% on 09/29/23
  • Put/Call Vol Ratio 0.22
  • Today's Volume 231
  • Volume Avg (30-Day) 629
  • Put/Call OI Ratio 1.53
  • Today's Open Interest 20,297
  • Open Int (30-Day) 16,229

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.86
  • Number of Estimates 7
  • High Estimate -0.68
  • Low Estimate -1.01
  • Prior Year -0.85
  • Growth Rate Est. (year over year) -1.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.79 +22.58%
on 02/14/24
47.58 -7.80%
on 03/04/24
+6.79 (+18.31%)
since 02/02/24
3-Month
32.56 +34.76%
on 12/11/23
47.58 -7.80%
on 03/04/24
+10.47 (+31.35%)
since 12/04/23
52-Week
15.23 +188.05%
on 03/28/23
47.58 -7.80%
on 03/04/24
+24.71 (+128.97%)
since 03/03/23

Most Recent Stories

More News
Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END

ONCY : 0.9800 (-12.50%)
ONC.TO : 1.36 (-9.93%)
GNLX : 6.91 (-4.95%)
CRNX : 43.34 (-5.84%)
PFE : 25.69 (-3.38%)
SGEN : 228.74 (-0.07%)
Up 83% in 5 Days, Is Crinetics Pharmaceuticals a Buy?

Despite good results in phase 3 trials, there are barriers to its drug candidate's success.

CRNX : 43.34 (-5.84%)
Why Crinetics Pharmaceuticals Stock Soared This Week

A positive late-stage trial readout fueled a major rally in the drugmaker's shares.

CRNX : 43.34 (-5.84%)
Stocks Settle Higher as Tesla’s Surge Powers Gains in Tech Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.67%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.19%....

$SPX : 5,135.92 (-0.02%)
SPY : 512.72 (-0.03%)
$DOWI : 38,998.29 (-0.23%)
DIA : 390.18 (-0.29%)
$IUXX : 18,269.80 (-0.18%)
QQQ : 444.86 (-0.17%)
TSLA : 187.50 (-7.47%)
CVS : 73.99 (+0.20%)
QCOM : 167.36 (+2.62%)
MTB : 140.61 (+2.70%)
KVUE : 18.95 (+0.69%)
DXCM : 122.35 (+0.50%)
Why Shares of Crinetics Pharmaceuticals Are Jumping Monday

The biotech company reported positive phase 3 trial results.

CRNX : 43.34 (-5.84%)
Stocks Climb on Strength in Tech Stocks and Favorable Chinese News

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Stock...

$SPX : 5,135.92 (-0.02%)
SPY : 512.72 (-0.03%)
$DOWI : 38,998.29 (-0.23%)
DIA : 390.18 (-0.29%)
$IUXX : 18,269.80 (-0.18%)
QQQ : 444.86 (-0.17%)
TSLA : 187.50 (-7.47%)
DIS : 113.65 (+1.52%)
CHTR : 278.32 (-5.06%)
STT : 74.38 (+0.72%)
KVUE : 18.95 (+0.69%)
QCOM : 167.36 (+2.62%)
Markets Today: Stock Index Futures Climb on Strength in Tech Stocks and Positive China News

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.47%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.74%. Stock index futures this morning are moderately higher on...

ESH24 : 5,143.75 (-0.04%)
NQH24 : 18,306.25 (-0.17%)
TSLA : 187.50 (-7.47%)
QCOM : 167.36 (+2.62%)
MSFT : 415.20 (-0.07%)
TWNK : 33.30 (-0.15%)
SQ : 77.54 (-2.16%)
CRNX : 43.34 (-5.84%)
KVUE : 18.95 (+0.69%)
TENB : 47.83 (-0.56%)
RTX : 89.23 (-0.63%)
OVV : 49.01 (-2.76%)
Stocks Set to Open Higher as Investors Await U.S. Inflation Data, Yellen Comments Boost Sentiment

September S&P 500 futures (ESU23) are up +0.42%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.55% this morning as remarks from Treasury Secretary Janet Yellen bolstered hopes that the U.S....

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
SWBI : 13.38 (-1.33%)
KR : 49.62 (+0.94%)
BA : 200.60 (+0.30%)
1COV.D.DX : 49.510 (-1.90%)
TSLA : 187.50 (-7.47%)
CRNX : 43.34 (-5.84%)
TWNK : 33.30 (-0.15%)
DASH : 133.93 (+5.10%)
KVUE : 18.95 (+0.69%)
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates

Crinetics Pharmaceuticals, Inc. (CRNX) delivered earnings and revenue surprises of -3.66% and 325.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

CRNX : 43.34 (-5.84%)
RVMD : 29.47 (-1.11%)
Earnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q1 Earnings Expected to Decline

Crinetics Pharmaceuticals, Inc. (CRNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRNX : 43.34 (-5.84%)
ACRX : 0.8600 (+7.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly,...

See More

Key Turning Points

3rd Resistance Point 54.08
2nd Resistance Point 50.54
1st Resistance Point 48.29
Last Price 43.34
1st Support Level 42.50
2nd Support Level 38.96
3rd Support Level 36.71

See More

52-Week High 47.58
Last Price 43.34
Fibonacci 61.8% 35.22
Fibonacci 50% 31.41
Fibonacci 38.2% 27.59
52-Week Low 15.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar